Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers by convenience and grocery stores. However, new technology has allowed a new range of outlets including online sales and catalog. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and other products approved for use as a self-medication product.
For the purpose of this study, Kalorama Information has divided products into five general segments:
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2011. Historical data was provided for the years 2007 through 2010, with forecast data provided for 2012 through 2015. Compound annual growth rates (CAGRs) are provided for the 2007-2011 and 2011-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2011 with some reference for 2009 and 2010. The forecasted market analysis for 2011-2015 was largely based on demographic trends, new developments, and global expansion.
Of the many developments in the Over the Counter Drug market noted by Kalorama Information in this report, there has been a notable increased interest in consumer care divisions by leading companies such as Sanofi andBoehringer Ingelheim. The switch of Allegra to OTC was an important strategic move forSanofi and one of the key reasons for the purchase of Chattem in 2009.
Boehringer Ingelheim also expanded its investment in OTC with the creation ofRx-to-OTC switch unit in 2010, increasing global expansion--specifically inAsian markets, and new OTC product introductions in categories with limitedtreatments. More details on these types of developments at these and other companies are covered in this report.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook